Distinct proteins in protein corona of nanoparticles represent a promising venue for endogenous targeting Part I: In vitro release and intracellular uptake perspective
This data helps you make informed decisions about dose adjustments and evaluate your overall response
The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for
Whether this GSH store influences other liver functions (i.e., de novo lipogenesis) is unclear
Why Peptides Are in the News The current media storm is largely driven by metabolic peptides used for diabetes and weight loss, alongside a parallel underground market of research peptides marketed for performance, anti-ageing and recovery
Solubilization of active GLP-1 (7-36)amide receptors from RINm5F plasma membranes